This inventor holds 1 USPTO granted patent. Top assignee: Denki Kagaku Kogyo Kabushiki Kaisha. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Tatsuya Kato: Innovator in Therapeutic Drug Development
Introduction
Tatsuya Kato is a notable inventor based in Gotenba, Japan. He has made significant contributions to the field of therapeutic drugs, particularly in the treatment of joint disorders. His innovative approach combines hyaluronic acid with methotrexate, leading to advancements in medical treatments.
Latest Patents
Kato holds a patent for a hyaluronic acid-methotrexate conjugate. This invention aims to provide a therapeutic drug that is effective for joint disorders. The conjugate is designed such that methotrexate is linked to a hydroxy group of hyaluronic acid through a peptide chain linker. This linker consists of 1 to 8 amino acids and is conjugated via a carbamate group.
Career Highlights
Tatsuya Kato is associated with Denki Kagaku Kogyo Kabushiki Kaisha, a company known for its focus on chemical products and innovations. His work has been instrumental in developing new therapeutic options for patients suffering from joint disorders.
Collaborations
Kato has collaborated with notable colleagues, including Hitoshi Ikeya and Tadashi Morikawa. Their combined expertise has contributed to the advancement of research and development in their field.
Conclusion
Tatsuya Kato's innovative work in creating a hyaluronic acid-methotrexate conjugate showcases his commitment to improving therapeutic options for joint disorders. His contributions are paving the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile